APA

Zambrano-Estrada X., Landaverde-Quiroz B., Dueñas-Bocanegra A. A., De Paz-Campos M. A., Hernández-Alberto G., Solorio-Perusquia B., Trejo-Mandujano M., Pérez-Guerrero L., Delgado-González E., Anguiano B. & Aceves C. (20180816). Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer. : BMC veterinary research.

Chicago

Zambrano-Estrada Xóchitl, Landaverde-Quiroz Brianda, Dueñas-Bocanegra Andrés A, De Paz-Campos Marco A, Hernández-Alberto Gerardo, Solorio-Perusquia Benjamín, Trejo-Mandujano Manuel, Pérez-Guerrero Laura, Delgado-González Evangelina, Anguiano Brenda and Aceves Carmen. 20180816. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer. : BMC veterinary research.

Harvard

Zambrano-Estrada X., Landaverde-Quiroz B., Dueñas-Bocanegra A. A., De Paz-Campos M. A., Hernández-Alberto G., Solorio-Perusquia B., Trejo-Mandujano M., Pérez-Guerrero L., Delgado-González E., Anguiano B. and Aceves C. (20180816). Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer. : BMC veterinary research.

MLA

Zambrano-Estrada Xóchitl, Landaverde-Quiroz Brianda, Dueñas-Bocanegra Andrés A, De Paz-Campos Marco A, Hernández-Alberto Gerardo, Solorio-Perusquia Benjamín, Trejo-Mandujano Manuel, Pérez-Guerrero Laura, Delgado-González Evangelina, Anguiano Brenda and Aceves Carmen. Molecular iodine/doxorubicin neoadjuvant treatment impair invasive capacity and attenuate side effect in canine mammary cancer. : BMC veterinary research. 20180816.